2022
DOI: 10.1007/s11154-022-09732-x
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic actions of the growth hormone-insulin growth factor-1 axis and its interaction with the central nervous system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 133 publications
0
4
0
Order By: Relevance
“…Alternatively, the human hepatocytes can also respond to these signals in a different manner that does not result in the rhythmic activation of the mTOR pathway. The inappropriate response of human hepatocytes to mouse signals is also illustrated by the blunted response to Growth Hormone (GH), an important regulator of the sex biased liver function and metabolism (Al-Massadi et al, 2022; Lichanska and Waters, 2008). Indeed, endogenous mouse GH is high while IGF-1 is low in LHM ( Figure S1G ).…”
Section: Resultsmentioning
confidence: 99%
“…Alternatively, the human hepatocytes can also respond to these signals in a different manner that does not result in the rhythmic activation of the mTOR pathway. The inappropriate response of human hepatocytes to mouse signals is also illustrated by the blunted response to Growth Hormone (GH), an important regulator of the sex biased liver function and metabolism (Al-Massadi et al, 2022; Lichanska and Waters, 2008). Indeed, endogenous mouse GH is high while IGF-1 is low in LHM ( Figure S1G ).…”
Section: Resultsmentioning
confidence: 99%
“…Several possible explanations have been proposed. Firstly, many obesity-related factors, such as insulin resistance, glucose homeostasis, and chronic in ammation, affect the GH/IGF-1 axis, leading to GH resistance and reducing circulating IGF-1 levels [29][30][31][32] . Secondly, hyperinsulinemia combined with obesity may down-regulate the expression level of IGF-1 binding proteins (IGF-BPs) and inhibit circulating IGF-1 through negative feedback regulation 33 .In addition, Bann et al 34 and Savastano al.…”
Section: Discussionmentioning
confidence: 99%
“…Regulated by hypothalamic secretion of GH-releasing hormone (GHRH), GH is a bone regulatory factor produced by the anterior pituitary gland that exerts a positive influence on bone mass. Numerous studies have demonstrated that GH primarily acts through the release of insulin-like growth factor 1 (IGF-1) [ 72 74 ], which bind to glycoprotein-coupled receptors on osteoblasts, thereby promoting osteoblast proliferation [ 50 , 73 ]. FSH, a major regulator of sex hormone secretion, is regulated by the hypothalamic secretion of gonadotropin-releasing hormone (GnRH).…”
Section: Bone-organ Axesmentioning
confidence: 99%